 |
|
QQ咨询:470003480 596799915
旺 旺: |
|
|
|
|
|
 |
|
|
|
 |
|
您现在的位置:首页 >>
蛋白质研究 >> 蛋白质纯化 |
|
22104
|
SM(PEG)4, 100 mg.
|
Pierce
|
100 MG
|
4557
|
详细查看 |
订购 |
|
22106
|
EMCH: N-(E-maleimidocaproic acid) hydrazide, 50 Mg.
|
Pierce
|
50 MG
|
2708
|
详细查看 |
订购 |
|
22107
|
SM(PEG)4
|
Pierce
|
1000 MG
|
18759
|
详细查看 |
订购 |
|
22108
|
SM(PEG)8, 100 mg.
|
Pierce
|
100 MG
|
4703
|
详细查看 |
订购 |
|
22111
|
KMUH: N-(k-maleimidoundecanoic acid) hydrazide, trifluoroac
|
Pierce
|
50 MG
|
4136
|
详细查看 |
订购 |
|
22112
|
原装现货|SM(PEG)12
|
Pierce
|
100 MG
|
4876
|
详细查看 |
订购 |
|
22113
|
SM(PEG)12
|
Pierce
|
1000 MG
|
21047
|
详细查看 |
订购 |
|
22114
|
SM(PEG)24
|
Pierce
|
100 MG
|
6130
|
详细查看 |
订购 |
|
22122
|
原装现货|Sulfo-SMCC, 1 g.
|
Pierce
|
1 G
|
29582
|
详细查看 |
订购 |
|
22212
|
Immobilized Mannan Binding Protein, 10 ml
|
Pierce
|
10 ML
|
13957
|
详细查看 |
订购 |
|
22295
|
AMAS: N-(alpha-maleimidoacetoxy) succinimide ester, 50 mg.
|
Pierce
|
50 MG
|
1793
|
详细查看 |
订购 |
|
22296
|
BMPA: N-B-maleimidopropionic acid, 100 Mg
|
Pierce
|
100 MG
|
724
|
详细查看 |
订购 |
|
22297
|
BMPH: N-(B-maleimidopropionic Acid) Hydrazide, trifluoroace
|
Pierce
|
50 MG
|
1848
|
详细查看 |
订购 |
|
22298
|
BMPS: N-(B-maleimidopropyloxy) succinimide ester, 50 Mg.
|
Pierce
|
50 MG
|
1775
|
详细查看 |
订购 |
|
22299
|
TFCS: N-(E-Trifluoroacetylcaproyloxy) succinimide ester,
|
Pierce
|
50 MG
|
1795
|
详细查看 |
订购 |
|
22301
|
PDPH: 3-(2-Pyridyldithio)Propionyl Hydrazide
|
Pierce
|
50 MG
|
2320
|
详细查看 |
订购 |
|
22305
|
原装现货|MPBH: 4-(4-N-Maleimidophenyl)Butyric Acid Hydrazide Hydrochl
|
Pierce
|
50 MG.
|
3422
|
详细查看 |
订购 |
|
22306
|
EMCA: e-Maleimidocaproic Acid, 1 Gm.
|
Pierce
|
1 GM
|
2764
|
详细查看 |
订购 |
|
22307
|
原装现货|Sulfo-EMCS-N-Sulfosuccinimide Este
|
Pierce
|
50 MG
|
3508
|
详细查看 |
订购 |
|
22309
|
原装现货|GMBS|N-gamma-maleimidobutyryloxysuccinimide Ester
|
Pierce
|
50 MG
|
2085
|
详细查看 |
订购 |
|
22311
|
原装现货|MBS|M-MALEIMIDOBENZOYL N-HYDROXYSUCCINIMIDE ESTER
|
Pierce
|
50 MG
|
1057
|
详细查看 |
订购 |
|
22312
|
Sulfo-MBS, m-maleimidobenzoyl-N-hydroxysulfosuccinimide este
|
Pierce
|
50 MG
|
2055
|
详细查看 |
订购 |
|
|
|
|
|
|
 |
 |
|